Stavros Manolagas
Concepts (410)
Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Bone and Bones | 38 | 2023 | 469 | 6.530 |
Why?
| Osteoblasts | 45 | 2022 | 450 | 5.900 |
Why?
| Osteoclasts | 36 | 2023 | 425 | 4.000 |
Why?
| Estrogens | 20 | 2022 | 227 | 3.860 |
Why?
| Osteoporosis | 16 | 2021 | 146 | 3.560 |
Why?
| Osteocytes | 20 | 2015 | 207 | 2.960 |
Why?
| Bone Density | 30 | 2023 | 379 | 2.840 |
Why?
| Apoptosis | 29 | 2020 | 1101 | 2.700 |
Why?
| Estrogen Receptor alpha | 8 | 2016 | 89 | 2.640 |
Why?
| Glucocorticoids | 11 | 2017 | 219 | 2.510 |
Why?
| Aging | 18 | 2021 | 687 | 2.480 |
Why?
| Oxidative Stress | 15 | 2018 | 770 | 2.150 |
Why?
| Bone Remodeling | 14 | 2020 | 150 | 2.110 |
Why?
| Mice | 76 | 2023 | 5739 | 1.990 |
Why?
| Animals | 92 | 2023 | 13187 | 1.920 |
Why?
| Androgens | 6 | 2017 | 69 | 1.800 |
Why?
| Osteogenesis | 18 | 2023 | 352 | 1.650 |
Why?
| Signal Transduction | 20 | 2020 | 1618 | 1.640 |
Why?
| Bone Resorption | 15 | 2020 | 304 | 1.630 |
Why?
| Wnt Proteins | 10 | 2016 | 100 | 1.570 |
Why?
| Bone Diseases, Metabolic | 5 | 2022 | 74 | 1.510 |
Why?
| Cell Differentiation | 18 | 2020 | 651 | 1.370 |
Why?
| Parathyroid Hormone | 8 | 2010 | 147 | 1.330 |
Why?
| Forkhead Transcription Factors | 8 | 2016 | 112 | 1.290 |
Why?
| Stem Cells | 11 | 2019 | 171 | 1.290 |
Why?
| Prednisolone | 5 | 2011 | 55 | 1.140 |
Why?
| Mice, Inbred C57BL | 29 | 2019 | 1816 | 1.120 |
Why?
| Gonadal Steroid Hormones | 4 | 2016 | 42 | 1.100 |
Why?
| Receptors, Androgen | 4 | 2015 | 46 | 1.070 |
Why?
| RANK Ligand | 17 | 2023 | 179 | 1.070 |
Why?
| Calcification, Physiologic | 3 | 2020 | 41 | 0.940 |
Why?
| Wnt Signaling Pathway | 4 | 2016 | 92 | 0.920 |
Why?
| Chemokine CXCL12 | 2 | 2020 | 32 | 0.850 |
Why?
| Matrix Metalloproteinase 13 | 1 | 2022 | 10 | 0.840 |
Why?
| beta Catenin | 5 | 2014 | 102 | 0.830 |
Why?
| Extracellular Signal-Regulated MAP Kinases | 7 | 2010 | 83 | 0.810 |
Why?
| Ovariectomy | 7 | 2022 | 119 | 0.810 |
Why?
| Female | 50 | 2022 | 26472 | 0.770 |
Why?
| Periosteum | 2 | 2012 | 26 | 0.740 |
Why?
| Transcription, Genetic | 12 | 2015 | 369 | 0.710 |
Why?
| Hydrogen Peroxide | 5 | 2016 | 115 | 0.710 |
Why?
| Alkaline Phosphatase | 1 | 2020 | 94 | 0.700 |
Why?
| Cell Nucleus | 4 | 2013 | 183 | 0.670 |
Why?
| Gene Deletion | 9 | 2020 | 266 | 0.670 |
Why?
| Reactive Oxygen Species | 9 | 2018 | 408 | 0.660 |
Why?
| Estradiol | 6 | 2013 | 225 | 0.610 |
Why?
| Femur Head Necrosis | 1 | 2017 | 18 | 0.600 |
Why?
| Femur Head | 1 | 2017 | 26 | 0.600 |
Why?
| Osteonecrosis | 1 | 2017 | 34 | 0.590 |
Why?
| Cells, Cultured | 17 | 2020 | 1573 | 0.590 |
Why?
| Femur | 9 | 2016 | 133 | 0.570 |
Why?
| Alendronate | 4 | 2009 | 23 | 0.570 |
Why?
| Shc Signaling Adaptor Proteins | 3 | 2011 | 20 | 0.560 |
Why?
| Osteoprotegerin | 4 | 2016 | 52 | 0.530 |
Why?
| Biochemistry | 1 | 2015 | 5 | 0.520 |
Why?
| Male | 30 | 2022 | 25241 | 0.520 |
Why?
| Humans | 41 | 2023 | 49974 | 0.500 |
Why?
| Mice, Transgenic | 16 | 2021 | 555 | 0.490 |
Why?
| Enzyme Activation | 9 | 2015 | 276 | 0.480 |
Why?
| bcl-2 Homologous Antagonist-Killer Protein | 1 | 2014 | 17 | 0.460 |
Why?
| bcl-2-Associated X Protein | 1 | 2014 | 56 | 0.460 |
Why?
| Mice, Knockout | 13 | 2022 | 841 | 0.450 |
Why?
| Fractures, Spontaneous | 1 | 2013 | 16 | 0.450 |
Why?
| Models, Biological | 10 | 2015 | 727 | 0.450 |
Why?
| Porosity | 4 | 2017 | 30 | 0.440 |
Why?
| Spinal Fractures | 1 | 2013 | 38 | 0.440 |
Why?
| Steroids | 1 | 2013 | 57 | 0.430 |
Why?
| Cell Lineage | 5 | 2016 | 83 | 0.410 |
Why?
| Dexamethasone | 4 | 2011 | 430 | 0.410 |
Why?
| Cell Count | 6 | 2020 | 147 | 0.410 |
Why?
| Transcription Factors | 8 | 2013 | 561 | 0.400 |
Why?
| NF-kappa B | 4 | 2017 | 314 | 0.390 |
Why?
| Homeodomain Proteins | 3 | 2022 | 80 | 0.390 |
Why?
| Tumor Necrosis Factor-alpha | 3 | 2016 | 388 | 0.390 |
Why?
| TCF Transcription Factors | 2 | 2007 | 11 | 0.370 |
Why?
| Phospholipids | 2 | 2021 | 57 | 0.370 |
Why?
| Spine | 6 | 2016 | 94 | 0.370 |
Why?
| Homeostasis | 4 | 2017 | 200 | 0.370 |
Why?
| Pain | 1 | 2013 | 379 | 0.370 |
Why?
| Cell Line | 11 | 2011 | 1000 | 0.360 |
Why?
| Muscle, Skeletal | 2 | 2015 | 750 | 0.360 |
Why?
| Orchiectomy | 2 | 2015 | 41 | 0.360 |
Why?
| Protein Kinase C | 1 | 2010 | 71 | 0.360 |
Why?
| Disease Models, Animal | 2 | 2016 | 1455 | 0.360 |
Why?
| Membrane Glycoproteins | 4 | 2006 | 240 | 0.350 |
Why?
| Hyperparathyroidism | 2 | 2011 | 31 | 0.350 |
Why?
| Bone Diseases | 2 | 2010 | 99 | 0.350 |
Why?
| Carrier Proteins | 4 | 2006 | 304 | 0.340 |
Why?
| Water | 1 | 2009 | 77 | 0.340 |
Why?
| Menopause | 1 | 2010 | 55 | 0.340 |
Why?
| Neovascularization, Physiologic | 1 | 2009 | 68 | 0.340 |
Why?
| Mitosis | 2 | 2008 | 91 | 0.330 |
Why?
| Mitogen-Activated Protein Kinases | 4 | 2015 | 155 | 0.320 |
Why?
| Organ Size | 4 | 2016 | 226 | 0.320 |
Why?
| Calcium | 5 | 2014 | 396 | 0.320 |
Why?
| Interleukin-6 | 4 | 2016 | 264 | 0.320 |
Why?
| Oxidoreductases Acting on CH-CH Group Donors | 1 | 2008 | 10 | 0.320 |
Why?
| Mitochondria | 3 | 2021 | 402 | 0.320 |
Why?
| Receptors, Estrogen | 2 | 2006 | 130 | 0.310 |
Why?
| Bone Density Conservation Agents | 1 | 2009 | 77 | 0.310 |
Why?
| Phosphorylation | 7 | 2010 | 535 | 0.310 |
Why?
| Gene Expression Regulation | 8 | 2020 | 976 | 0.310 |
Why?
| Cholesterol | 1 | 2008 | 146 | 0.300 |
Why?
| Estrenes | 2 | 2006 | 13 | 0.300 |
Why?
| Phosphatidylinositol 3-Kinases | 2 | 2005 | 141 | 0.300 |
Why?
| Glucose | 2 | 2016 | 344 | 0.280 |
Why?
| Osteoporosis, Postmenopausal | 1 | 2006 | 32 | 0.280 |
Why?
| Nerve Tissue Proteins | 1 | 2008 | 193 | 0.270 |
Why?
| Blotting, Western | 7 | 2016 | 601 | 0.270 |
Why?
| JNK Mitogen-Activated Protein Kinases | 2 | 2007 | 72 | 0.270 |
Why?
| Scavenger Receptors, Class B | 2 | 2023 | 10 | 0.260 |
Why?
| X-Ray Microtomography | 5 | 2016 | 77 | 0.260 |
Why?
| Receptors, Calcitriol | 1 | 2005 | 19 | 0.250 |
Why?
| Mitogen-Activated Protein Kinase Kinases | 1 | 2005 | 33 | 0.250 |
Why?
| Calcitriol | 1 | 2005 | 36 | 0.250 |
Why?
| Sirtuin 1 | 2 | 2015 | 28 | 0.250 |
Why?
| Bone Development | 3 | 2014 | 65 | 0.250 |
Why?
| Hormone Replacement Therapy | 1 | 2004 | 27 | 0.240 |
Why?
| src-Family Kinases | 1 | 2005 | 51 | 0.240 |
Why?
| Enhancer Elements, Genetic | 3 | 2011 | 61 | 0.240 |
Why?
| RNA | 3 | 2023 | 170 | 0.240 |
Why?
| Vesicular Transport Proteins | 2 | 2016 | 34 | 0.240 |
Why?
| Reverse Transcriptase Polymerase Chain Reaction | 8 | 2016 | 595 | 0.240 |
Why?
| Pseudohypoparathyroidism | 1 | 2003 | 1 | 0.230 |
Why?
| Cell Proliferation | 5 | 2018 | 1007 | 0.230 |
Why?
| Cell Survival | 7 | 2012 | 600 | 0.220 |
Why?
| Integrases | 4 | 2016 | 43 | 0.210 |
Why?
| Reproducibility of Results | 2 | 2018 | 1193 | 0.210 |
Why?
| Oxidation-Reduction | 5 | 2020 | 322 | 0.210 |
Why?
| Adipogenesis | 2 | 2020 | 51 | 0.210 |
Why?
| Stress, Mechanical | 3 | 2013 | 88 | 0.210 |
Why?
| Osteocalcin | 2 | 2020 | 43 | 0.200 |
Why?
| Cyclic AMP Response Element-Binding Protein | 4 | 2013 | 34 | 0.200 |
Why?
| Diphosphonates | 3 | 2008 | 90 | 0.200 |
Why?
| Adenosine Triphosphate | 2 | 2020 | 233 | 0.200 |
Why?
| Sirtuin 3 | 1 | 2021 | 19 | 0.190 |
Why?
| Up-Regulation | 3 | 2010 | 452 | 0.190 |
Why?
| Gene Expression Regulation, Enzymologic | 3 | 2014 | 181 | 0.190 |
Why?
| Bone Marrow Cells | 3 | 2015 | 191 | 0.180 |
Why?
| Monocyte-Macrophage Precursor Cells | 1 | 2020 | 7 | 0.180 |
Why?
| RNA, Messenger | 7 | 2010 | 1105 | 0.180 |
Why?
| Oxidative Phosphorylation | 1 | 2020 | 39 | 0.180 |
Why?
| DNA-Binding Proteins | 1 | 2003 | 427 | 0.180 |
Why?
| Gene Knock-In Techniques | 2 | 2010 | 22 | 0.180 |
Why?
| Cell Division | 2 | 2015 | 292 | 0.180 |
Why?
| Atherosclerosis | 2 | 2016 | 214 | 0.170 |
Why?
| Transfection | 6 | 2007 | 354 | 0.170 |
Why?
| Connexin 43 | 4 | 2008 | 25 | 0.160 |
Why?
| MAP Kinase Kinase 4 | 2 | 2011 | 29 | 0.160 |
Why?
| Bone Morphogenetic Proteins | 2 | 2010 | 56 | 0.160 |
Why?
| Ligands | 5 | 2007 | 204 | 0.160 |
Why?
| Bone Morphogenetic Protein 2 | 2 | 2010 | 46 | 0.160 |
Why?
| Proto-Oncogene Proteins c-akt | 2 | 2011 | 157 | 0.160 |
Why?
| Immunoglobulin M | 1 | 2018 | 52 | 0.160 |
Why?
| Single-Chain Antibodies | 1 | 2018 | 21 | 0.160 |
Why?
| Epitopes | 1 | 2018 | 59 | 0.150 |
Why?
| Phenotype | 4 | 2015 | 729 | 0.150 |
Why?
| Biological Evolution | 1 | 2018 | 32 | 0.150 |
Why?
| Lipid Metabolism | 2 | 2009 | 175 | 0.150 |
Why?
| Adaptor Proteins, Signal Transducing | 3 | 2016 | 197 | 0.140 |
Why?
| Myeloid Cells | 1 | 2016 | 38 | 0.140 |
Why?
| Glycoproteins | 2 | 2010 | 115 | 0.140 |
Why?
| rab GTP-Binding Proteins | 1 | 2016 | 35 | 0.140 |
Why?
| HeLa Cells | 4 | 2005 | 250 | 0.140 |
Why?
| Autophagy | 2 | 2015 | 169 | 0.140 |
Why?
| Lysosomes | 1 | 2016 | 64 | 0.140 |
Why?
| Quantitative Trait Loci | 2 | 2006 | 42 | 0.140 |
Why?
| Apolipoproteins E | 1 | 2016 | 56 | 0.130 |
Why?
| Protein Structure, Tertiary | 3 | 2007 | 253 | 0.130 |
Why?
| Gene Expression | 4 | 2023 | 609 | 0.130 |
Why?
| Body Weight | 2 | 2010 | 513 | 0.130 |
Why?
| Diabetes Mellitus, Experimental | 1 | 2016 | 129 | 0.130 |
Why?
| Time Factors | 6 | 2008 | 2903 | 0.130 |
Why?
| History, 21st Century | 1 | 2015 | 56 | 0.130 |
Why?
| Cyclic AMP-Dependent Protein Kinases | 3 | 2004 | 51 | 0.130 |
Why?
| Absorptiometry, Photon | 4 | 2016 | 154 | 0.130 |
Why?
| History, 20th Century | 1 | 2015 | 99 | 0.120 |
Why?
| Microtubule-Associated Proteins | 2 | 2013 | 67 | 0.120 |
Why?
| Aorta | 1 | 2016 | 161 | 0.120 |
Why?
| Sarcopenia | 1 | 2015 | 84 | 0.120 |
Why?
| National Institutes of Health (U.S.) | 1 | 2014 | 46 | 0.120 |
Why?
| Calcium, Dietary | 1 | 2014 | 13 | 0.120 |
Why?
| Lumbar Vertebrae | 2 | 2013 | 98 | 0.120 |
Why?
| Catalase | 1 | 2014 | 67 | 0.120 |
Why?
| Diabetes Mellitus, Type 1 | 1 | 2016 | 198 | 0.120 |
Why?
| FMN Reductase | 1 | 2013 | 3 | 0.110 |
Why?
| Cytoplasm | 2 | 2004 | 90 | 0.110 |
Why?
| Plasmids | 2 | 2004 | 161 | 0.110 |
Why?
| Fracture Healing | 1 | 2013 | 27 | 0.110 |
Why?
| Receptor Activator of Nuclear Factor-kappa B | 4 | 2006 | 30 | 0.110 |
Why?
| Atrophy | 1 | 2013 | 38 | 0.110 |
Why?
| Mice, Mutant Strains | 1 | 2012 | 71 | 0.110 |
Why?
| Cell Cycle Proteins | 2 | 2013 | 166 | 0.110 |
Why?
| Dose-Response Relationship, Drug | 2 | 2009 | 1376 | 0.110 |
Why?
| Iron | 1 | 2013 | 122 | 0.100 |
Why?
| Bone Marrow | 2 | 2013 | 362 | 0.100 |
Why?
| Uterus | 1 | 2013 | 94 | 0.100 |
Why?
| Organ Specificity | 2 | 2010 | 108 | 0.100 |
Why?
| Research Design | 1 | 2014 | 344 | 0.100 |
Why?
| 11-beta-Hydroxysteroid Dehydrogenase Type 2 | 2 | 2009 | 12 | 0.100 |
Why?
| Receptors, Cytoplasmic and Nuclear | 2 | 2002 | 64 | 0.100 |
Why?
| Bone Demineralization, Pathologic | 1 | 2011 | 5 | 0.100 |
Why?
| Dyneins | 1 | 2011 | 5 | 0.100 |
Why?
| 1-Alkyl-2-acetylglycerophosphocholine Esterase | 1 | 2011 | 6 | 0.100 |
Why?
| Macrophages | 2 | 2016 | 363 | 0.100 |
Why?
| Bone Matrix | 1 | 2011 | 18 | 0.100 |
Why?
| Lactation | 1 | 2011 | 62 | 0.100 |
Why?
| TNF-Related Apoptosis-Inducing Ligand | 1 | 2011 | 20 | 0.100 |
Why?
| B-Lymphocytes | 1 | 2012 | 170 | 0.100 |
Why?
| PPAR gamma | 2 | 2009 | 73 | 0.100 |
Why?
| Membrane Proteins | 1 | 2013 | 341 | 0.090 |
Why?
| Linear Models | 2 | 2009 | 280 | 0.090 |
Why?
| Solubility | 1 | 2010 | 69 | 0.090 |
Why?
| Oxidants | 1 | 2010 | 53 | 0.090 |
Why?
| Genetic Markers | 1 | 2010 | 102 | 0.090 |
Why?
| Genes, Reporter | 2 | 2017 | 89 | 0.090 |
Why?
| Smad1 Protein | 1 | 2010 | 5 | 0.090 |
Why?
| Glutathione Reductase | 1 | 2010 | 14 | 0.090 |
Why?
| Intercellular Signaling Peptides and Proteins | 1 | 2010 | 104 | 0.090 |
Why?
| Turner Syndrome | 1 | 2010 | 15 | 0.090 |
Why?
| Chimera | 1 | 2010 | 9 | 0.090 |
Why?
| Green Fluorescent Proteins | 3 | 2005 | 90 | 0.090 |
Why?
| Transgenes | 1 | 2010 | 55 | 0.090 |
Why?
| Gene Targeting | 1 | 2010 | 29 | 0.090 |
Why?
| Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2009 | 56 | 0.090 |
Why?
| Cell Death | 1 | 2010 | 181 | 0.080 |
Why?
| Acid Phosphatase | 1 | 2009 | 11 | 0.080 |
Why?
| Vascular Endothelial Growth Factor A | 1 | 2009 | 201 | 0.080 |
Why?
| Thymidine Kinase | 1 | 2008 | 19 | 0.080 |
Why?
| Ganciclovir | 1 | 2008 | 24 | 0.080 |
Why?
| Skull | 2 | 2009 | 75 | 0.080 |
Why?
| Receptors, Parathyroid Hormone | 1 | 2008 | 9 | 0.080 |
Why?
| Cell Membrane | 2 | 2007 | 248 | 0.080 |
Why?
| Isoenzymes | 1 | 2009 | 168 | 0.080 |
Why?
| Receptor, Parathyroid Hormone, Type 1 | 1 | 2008 | 24 | 0.080 |
Why?
| Multienzyme Complexes | 2 | 2009 | 34 | 0.080 |
Why?
| Postmenopause | 1 | 2009 | 100 | 0.080 |
Why?
| Multipotent Stem Cells | 1 | 2007 | 3 | 0.080 |
Why?
| Blotting, Northern | 2 | 2005 | 109 | 0.080 |
Why?
| Collagen Type I | 1 | 2008 | 89 | 0.080 |
Why?
| Mutagenesis, Site-Directed | 1 | 2007 | 99 | 0.070 |
Why?
| DNA Replication | 1 | 2008 | 150 | 0.070 |
Why?
| Estrogen Antagonists | 2 | 2007 | 21 | 0.070 |
Why?
| Hormones | 1 | 2007 | 55 | 0.070 |
Why?
| Focal Adhesion Kinase 1 | 1 | 2007 | 15 | 0.070 |
Why?
| Molecular Structure | 2 | 2006 | 297 | 0.070 |
Why?
| Anoikis | 1 | 2007 | 8 | 0.070 |
Why?
| Focal Adhesion Kinase 2 | 1 | 2007 | 13 | 0.070 |
Why?
| Extracellular Matrix | 1 | 2007 | 111 | 0.070 |
Why?
| Dihydrotestosterone | 1 | 2006 | 12 | 0.070 |
Why?
| X Chromosome | 1 | 2006 | 13 | 0.070 |
Why?
| Estrogen Receptor beta | 1 | 2007 | 54 | 0.070 |
Why?
| Mechanotransduction, Cellular | 1 | 2007 | 36 | 0.070 |
Why?
| Double-Blind Method | 1 | 2009 | 681 | 0.070 |
Why?
| Smad Proteins | 1 | 2006 | 11 | 0.070 |
Why?
| Response Elements | 1 | 2006 | 29 | 0.070 |
Why?
| MAP Kinase Signaling System | 1 | 2007 | 119 | 0.070 |
Why?
| Biopsy | 1 | 2009 | 584 | 0.070 |
Why?
| Teriparatide | 1 | 2006 | 11 | 0.070 |
Why?
| Weightlessness | 1 | 2006 | 14 | 0.070 |
Why?
| Proto-Oncogene Proteins | 2 | 2005 | 149 | 0.070 |
Why?
| Kinetics | 2 | 2004 | 623 | 0.070 |
Why?
| Extracellular Matrix Proteins | 3 | 2014 | 69 | 0.070 |
Why?
| Transforming Growth Factor beta | 1 | 2006 | 144 | 0.070 |
Why?
| Synteny | 1 | 2005 | 7 | 0.070 |
Why?
| Chromosomes, Human, X | 1 | 2005 | 19 | 0.070 |
Why?
| Lipoproteins, LDL | 2 | 2018 | 170 | 0.060 |
Why?
| Histocytochemistry | 1 | 2005 | 44 | 0.060 |
Why?
| Protein Binding | 4 | 2011 | 660 | 0.060 |
Why?
| Antioxidants | 1 | 2007 | 249 | 0.060 |
Why?
| Endosomes | 2 | 2016 | 30 | 0.060 |
Why?
| Chromosome Mapping | 1 | 2005 | 156 | 0.060 |
Why?
| Adipocytes | 2 | 2004 | 121 | 0.060 |
Why?
| Cholera Toxin | 1 | 2004 | 15 | 0.060 |
Why?
| Active Transport, Cell Nucleus | 1 | 2004 | 34 | 0.060 |
Why?
| Diet, High-Fat | 2 | 2018 | 222 | 0.060 |
Why?
| Mitogen-Activated Protein Kinase 1 | 1 | 2004 | 51 | 0.060 |
Why?
| Fatty Acids, Unsaturated | 1 | 2004 | 39 | 0.060 |
Why?
| Etoposide | 1 | 2004 | 72 | 0.060 |
Why?
| Thiazolidinediones | 1 | 2004 | 82 | 0.060 |
Why?
| Compressive Strength | 1 | 2004 | 12 | 0.060 |
Why?
| Seminal Vesicles | 1 | 2004 | 13 | 0.060 |
Why?
| DNA Primers | 2 | 2014 | 207 | 0.060 |
Why?
| Nuclear Receptor Co-Repressor 1 | 1 | 2023 | 4 | 0.060 |
Why?
| Rats | 2 | 2008 | 3305 | 0.060 |
Why?
| United States | 1 | 2014 | 4860 | 0.060 |
Why?
| Co-Repressor Proteins | 1 | 2023 | 19 | 0.060 |
Why?
| ets-Domain Protein Elk-1 | 1 | 2003 | 5 | 0.060 |
Why?
| CCAAT-Enhancer-Binding Protein-alpha | 1 | 2003 | 5 | 0.060 |
Why?
| Diabetes Mellitus | 1 | 2007 | 285 | 0.060 |
Why?
| Cysteine Endopeptidases | 1 | 2003 | 67 | 0.060 |
Why?
| Phosphotransferases | 1 | 2003 | 16 | 0.060 |
Why?
| Arachidonate 12-Lipoxygenase | 2 | 2016 | 13 | 0.060 |
Why?
| Arachidonate 15-Lipoxygenase | 2 | 2016 | 13 | 0.060 |
Why?
| Proto-Oncogene Proteins c-fos | 1 | 2003 | 61 | 0.060 |
Why?
| Selective Estrogen Receptor Modulators | 1 | 2003 | 24 | 0.060 |
Why?
| Proto-Oncogene Proteins c-jun | 1 | 2003 | 75 | 0.050 |
Why?
| Mice, 129 Strain | 2 | 2013 | 38 | 0.050 |
Why?
| Core Binding Factor Alpha 1 Subunit | 3 | 2009 | 44 | 0.050 |
Why?
| Mutation | 2 | 2007 | 1294 | 0.050 |
Why?
| Immunoblotting | 2 | 2015 | 118 | 0.050 |
Why?
| Receptors, Scavenger | 1 | 2022 | 29 | 0.050 |
Why?
| Age Factors | 2 | 2020 | 1087 | 0.050 |
Why?
| Down-Regulation | 1 | 2003 | 348 | 0.050 |
Why?
| Analysis of Variance | 2 | 2014 | 562 | 0.050 |
Why?
| Genitalia | 1 | 2001 | 11 | 0.050 |
Why?
| DNA | 1 | 2005 | 541 | 0.050 |
Why?
| Luminescent Proteins | 2 | 2017 | 53 | 0.050 |
Why?
| Neoplasm Proteins | 1 | 2003 | 322 | 0.050 |
Why?
| Radiography | 2 | 2013 | 489 | 0.050 |
Why?
| Cardiovascular System | 1 | 2001 | 49 | 0.050 |
Why?
| Central Nervous System | 1 | 2001 | 85 | 0.050 |
Why?
| Adult | 2 | 2009 | 13236 | 0.050 |
Why?
| Antibodies, Neutralizing | 1 | 2020 | 64 | 0.050 |
Why?
| Alleles | 2 | 2012 | 250 | 0.040 |
Why?
| Base Sequence | 2 | 2014 | 643 | 0.040 |
Why?
| Sex Characteristics | 1 | 2001 | 190 | 0.040 |
Why?
| Cattle | 2 | 2009 | 210 | 0.040 |
Why?
| GATA4 Transcription Factor | 1 | 2017 | 11 | 0.040 |
Why?
| G1 Phase Cell Cycle Checkpoints | 1 | 2017 | 17 | 0.040 |
Why?
| Cyclin-Dependent Kinase Inhibitor p21 | 1 | 2017 | 67 | 0.040 |
Why?
| Primary Cell Culture | 1 | 2017 | 61 | 0.040 |
Why?
| Aniline Compounds | 1 | 2017 | 43 | 0.040 |
Why?
| Mice, Inbred BALB C | 1 | 2017 | 304 | 0.040 |
Why?
| Models, Animal | 1 | 2017 | 233 | 0.040 |
Why?
| Immunomagnetic Separation | 1 | 2016 | 7 | 0.030 |
Why?
| Genotype | 2 | 2008 | 537 | 0.030 |
Why?
| Middle Aged | 2 | 2009 | 12069 | 0.030 |
Why?
| Sulfonamides | 1 | 2017 | 129 | 0.030 |
Why?
| Embryo, Mammalian | 2 | 2009 | 66 | 0.030 |
Why?
| Species Specificity | 2 | 2006 | 192 | 0.030 |
Why?
| Heme Oxygenase-1 | 1 | 2015 | 19 | 0.030 |
Why?
| Tumor Suppressor Protein p53 | 1 | 2017 | 202 | 0.030 |
Why?
| Interleukin-1beta | 1 | 2016 | 75 | 0.030 |
Why?
| Acetylation | 1 | 2015 | 97 | 0.030 |
Why?
| Monocytes | 1 | 2016 | 131 | 0.030 |
Why?
| DNA Damage | 1 | 2017 | 301 | 0.030 |
Why?
| Recombination, Genetic | 1 | 2015 | 96 | 0.030 |
Why?
| Histones | 1 | 2017 | 312 | 0.030 |
Why?
| Hyperthyroidism | 1 | 2014 | 27 | 0.030 |
Why?
| Fibroblasts | 2 | 2009 | 345 | 0.030 |
Why?
| Real-Time Polymerase Chain Reaction | 1 | 2014 | 181 | 0.030 |
Why?
| Gene Knockout Techniques | 1 | 2013 | 40 | 0.030 |
Why?
| Polymorphism, Single Nucleotide | 2 | 2006 | 485 | 0.030 |
Why?
| Gene Knockdown Techniques | 1 | 2013 | 106 | 0.030 |
Why?
| Flow Cytometry | 1 | 2016 | 476 | 0.030 |
Why?
| Fatty Acids | 2 | 2004 | 146 | 0.030 |
Why?
| Cathepsin K | 1 | 2011 | 7 | 0.030 |
Why?
| Adiposity | 1 | 2013 | 127 | 0.030 |
Why?
| Histological Techniques | 1 | 2011 | 8 | 0.030 |
Why?
| Inflammation | 1 | 2016 | 604 | 0.020 |
Why?
| Chondrocytes | 1 | 2011 | 41 | 0.020 |
Why?
| Oxandrolone | 1 | 2010 | 10 | 0.020 |
Why?
| Polymerase Chain Reaction | 1 | 2011 | 453 | 0.020 |
Why?
| T-Lymphocytes | 1 | 2012 | 338 | 0.020 |
Why?
| Cartilage | 1 | 2010 | 48 | 0.020 |
Why?
| Body Height | 1 | 2010 | 65 | 0.020 |
Why?
| Core Binding Factor beta Subunit | 1 | 2009 | 3 | 0.020 |
Why?
| Aldehydes | 1 | 2009 | 83 | 0.020 |
Why?
| Electrophoretic Mobility Shift Assay | 1 | 2009 | 73 | 0.020 |
Why?
| Stromal Cells | 1 | 2009 | 72 | 0.020 |
Why?
| RNA, Small Interfering | 1 | 2009 | 215 | 0.020 |
Why?
| Vitamin D | 1 | 2009 | 88 | 0.020 |
Why?
| Gene Silencing | 1 | 2008 | 119 | 0.020 |
Why?
| Phosphoproteins | 1 | 2008 | 107 | 0.020 |
Why?
| Lymphoid Tissue | 1 | 2007 | 21 | 0.020 |
Why?
| Caveolin 1 | 1 | 2007 | 21 | 0.020 |
Why?
| Weight Gain | 1 | 2008 | 240 | 0.020 |
Why?
| Transcription Initiation Site | 1 | 2006 | 13 | 0.020 |
Why?
| Base Pairing | 1 | 2006 | 27 | 0.020 |
Why?
| Conserved Sequence | 1 | 2006 | 56 | 0.020 |
Why?
| Cyclic AMP | 1 | 2006 | 90 | 0.020 |
Why?
| Promoter Regions, Genetic | 1 | 2008 | 475 | 0.020 |
Why?
| Caspase 3 | 1 | 2006 | 97 | 0.020 |
Why?
| Wnt3 Protein | 1 | 2005 | 7 | 0.020 |
Why?
| Wnt1 Protein | 1 | 2005 | 10 | 0.020 |
Why?
| Culture Media, Serum-Free | 1 | 2005 | 15 | 0.020 |
Why?
| Cycloheximide | 1 | 2005 | 37 | 0.020 |
Why?
| Wnt3A Protein | 1 | 2005 | 11 | 0.020 |
Why?
| Crosses, Genetic | 1 | 2005 | 31 | 0.020 |
Why?
| Caspases | 1 | 2006 | 104 | 0.020 |
Why?
| Culture Media | 1 | 2005 | 94 | 0.020 |
Why?
| Binding Sites | 1 | 2006 | 374 | 0.020 |
Why?
| Haplotypes | 1 | 2005 | 83 | 0.020 |
Why?
| Densitometry | 1 | 2004 | 11 | 0.020 |
Why?
| Ribosomal Protein S6 Kinases, 90-kDa | 1 | 2004 | 7 | 0.020 |
Why?
| Molecular Sequence Data | 1 | 2006 | 792 | 0.020 |
Why?
| Mesoderm | 1 | 2004 | 27 | 0.020 |
Why?
| Drug Synergism | 1 | 2004 | 150 | 0.020 |
Why?
| Sex Factors | 1 | 2006 | 691 | 0.010 |
Why?
| Free Radical Scavengers | 1 | 2004 | 25 | 0.010 |
Why?
| Tensile Strength | 1 | 2003 | 28 | 0.010 |
Why?
| bcl-Associated Death Protein | 1 | 2003 | 9 | 0.010 |
Why?
| Dactinomycin | 1 | 2003 | 22 | 0.010 |
Why?
| Culture Media, Conditioned | 1 | 2003 | 48 | 0.010 |
Why?
| Genetic Predisposition to Disease | 1 | 2006 | 510 | 0.010 |
Why?
| Acetylcysteine | 1 | 2004 | 100 | 0.010 |
Why?
| Enzyme Inhibitors | 1 | 2005 | 391 | 0.010 |
Why?
| Models, Genetic | 1 | 2003 | 170 | 0.010 |
Why?
| Hypoglycemic Agents | 1 | 2004 | 168 | 0.010 |
Why?
| Proteasome Endopeptidase Complex | 1 | 2003 | 114 | 0.010 |
Why?
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2003 | 129 | 0.010 |
Why?
| Receptors, Tumor Necrosis Factor | 1 | 2002 | 36 | 0.010 |
Why?
| Transcription Factor AP-1 | 1 | 2002 | 63 | 0.010 |
Why?
| Regulatory Sequences, Nucleic Acid | 1 | 2002 | 40 | 0.010 |
Why?
| src Homology Domains | 1 | 2001 | 8 | 0.010 |
Why?
| Chick Embryo | 1 | 2001 | 82 | 0.010 |
Why?
| Transcriptional Activation | 1 | 2002 | 121 | 0.010 |
Why?
| Adolescent | 1 | 2010 | 6356 | 0.010 |
Why?
| Child | 1 | 2010 | 6847 | 0.010 |
Why?
|
|
Manolagas's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Derived automatically based on a person's publications. Keywords from attributed publications are matched to keywords from the MeSH. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|